The government formally filed its notice of appeal of the stem cell injunction on August 27. Today it moved to stay the injunction, filing a memorandum in support of an emergency motion. The arguments focus primarily on the significant harm caused by the injunction to stem cell researchers and those who might benefit from it. They argue that the injunction effectively gives the plaintiffs favorable treatment in their adult stem cell work compared to the stoppage faced by their embryonic stem cell research colleagues. Aside from the issue of harms (which will likely be the biggest factor in the eventual decision), this does address the dubious standing that plaintiffs were granted – that funding embryonic stem cell research did them economic harm. Since the NIH has provided almost three times as much funding for adult stem cell research compared to embryonic stem cell research in fiscal year 2010, I think the standing issue has legs for appeal should the stay not be granted.
The last third of the document is a declaration from NIH Director Collins outlining the value of embryonic stem cell research and the harms the injunction may pose. It gets into specifics of some projects that will not be receiving funding should the injunction stand. It’s at least as interesting as the support memo.
